Ticker Details
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.
IPO Date:	June 25, 2014
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$811.75M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 1.69%
Avg Daily Range (30 D):	$0.42 | 2.12%
Avg Daily Range (90 D):	$0.42 | 1.89%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.52M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,592
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.64M
Avg Institutional Trade (90 D):	$1.62M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$1.57M
Avg Closing Trade (90 D):	$1.68M
Avg Closing Volume:	69.42K

News

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Jun 5, 2025 @ 5:00 PM Global Antidote Market to Cross the USD 4 Billion ... Source: Delveinsight

Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh

Jul 23, 2024 @ 5:01 PM HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 202... Source: N/A

May 30, 2024 @ 6:06 AM Amphastar Pharmaceuticals: Buy When Fear Is Overbl... Source: James Long

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.71	$.14	$.53
Diluted EPS	$1.66	$.14	$.51
Revenue	$720.53M	$171.17M	$183.11M
Gross Profit	$341.13M	$70.32M	$85.67M
Net Income / Loss	$79.23M	$6.42M	$24.43M
Operating Income / Loss	$116.74M	$13.63M	$35.61M
Cost of Revenue	$379.4M	$100.85M	$97.44M
Net Cash Flow	$-11.84M	$.76M	$-46.09M
PE Ratio